Furukawa Toshi A, Watanabe Norio, Omori Ichiro M, Churchill Rachel
Department of Psychiatry and Cognitive-Behavioral Medicine, Nagoya City University Graduate School of Medical Sciences, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan.
BMC Psychiatry. 2007 Dec 20;7:73. doi: 10.1186/1471-244X-7-73.
In a number of drug and psychotherapy comparative trials, psychotherapy-placebo combination has been assumed to represent psychotherapy. Whether psychotherapy plus pill placebo is the same as psychotherapy alone is an empirical question which however has to date never been examined systematically.
We conducted a systematic review and meta-analysis of randomised controlled trials (RCTs) that directly compared cognitive-behavior therapy (CBT) alone against CBT plus pill placebo in the treatment of panic disorder.
Extensive literature search was able to identify three relevant RCTs. At the end of the acute phase treatment, patients who received CBT plus placebo had 26% (95%CI: 2 to 55%) increased chances of responding than those who received CBT alone. At follow-up the difference was no longer statistically significant (22%, 95%CI: -10% to 64%).
The act of taking a pill placebo may enhance the placebo effect already contained in the effective psychotherapeutic intervention during the acute phase treatment. Theoretically this is an argument against the recently claimed null hypothesis of placebo effect in general and clinically it may point to some further room for enhancing the psychotherapeutic approach for panic disorder.
在一些药物与心理治疗的对比试验中,心理治疗与安慰剂联合使用被认为等同于心理治疗。心理治疗加药物安慰剂是否与单纯心理治疗相同是一个实证问题,但迄今为止从未进行过系统研究。
我们对随机对照试验(RCT)进行了系统评价和荟萃分析,这些试验直接比较了单纯认知行为疗法(CBT)与CBT加药物安慰剂治疗惊恐障碍的效果。
广泛的文献检索共识别出三项相关的随机对照试验。在急性期治疗结束时,接受CBT加安慰剂的患者比单纯接受CBT的患者有26%(95%CI:2%至55%)的更高反应几率。在随访时,差异不再具有统计学意义(22%,95%CI:-10%至64%)。
服用药物安慰剂的行为可能会增强急性期治疗中有效心理治疗干预中已包含的安慰剂效应。从理论上讲,这反对了最近普遍声称的安慰剂效应零假设,在临床上这可能表明在增强惊恐障碍心理治疗方法方面还有进一步的空间。